Monday, November 4, 2024

TOPIC

Clinical

News Reports

DCGI approves study at CMC Vellore to test efficacy of mixing doses of Covaxin and Covishield vaccines

OpIndia Staff -
CMC Vellore will conduct a study and clinical trial to determine if a person can take two different vaccine shots of Covidshield and Covaxin to complete the vaccination course.
News Reports

From reports of shortages to black-marketing, is Remdesivir really the ‘miracle drug’ to cure Covid?

Anurag -
In November 2020, World Health Organization (WHO) recommended against the use of Remdesivir in Covid-19 patients stating that there was no evidence that the drug can improve survival.
News Reports

Bharat Biotech’s Covaxin shows 81% efficacy, phase 3 trials with 25,800 subjects completed

OpIndia Staff -
The phase 3 trials involved 25,800 subjects. The trial, done in collaboration with ICMR, is the largest ever clinical trial done in India.
News Reports

Serum Institute halts trials of Oxford-AstraZeneca coronavirus vaccine in India after DCGI notice

OpIndia Staff -
DCGI had asked Serum Institute why it had not informed them about AstraZeneca halting its trials in other countries.
News Reports

Health Ministry cautions on use of plasma therapy for coronavirus, says it can be harmful as still being tested

OpIndia Staff -
The USFDA had also said that the plasma therapy has not yet been proven to be safe and efficient treatment for Chinese Coronavirus.
News Reports

Is Hindu Spirituality a Super Science?

Murali KV -
One might wonder why basic Biology matters to Hinduism... here is why

Latest News

Recently Popular

Contact: [email protected]

About us

News and opinion website that brings you reports and narrative from a perspective often ignored or suppressed by the mainstream media of India.

Follow us

© OpIndia.com